Diligence memo · auto-generated · as of July 2, 2026
Pharma-Labs Finance LLC
Pharma-Labs Finance LLC looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Pharma-Labs Finance LLC operates in Pharma, based in PHOENIX.
Sub-sector tags: pharma.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Pharma-Labs Finance LLC has raised $3.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.0M on 2020-06-29.
Most recent recorded round closed around 2020-06-29.
Valuation (modeled)modeled
Provath models Pharma-Labs Finance LLC at approximately $115M (range $2.3M–$899M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.01× the median modeled value of Seed Pharma companies in 2019–2021 (20 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 6.0 yr ago; this sector typically re-raises about every 16 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 49% of Pharma peers (310 compared).
Modeled value ranks above 69% of those peers.
Closest niche peers: Zoo Pharma Dynamics Inc., FSD Pharma Inc., Deepbiome Therapeutics, Inc., Pykus Therapeutics, Inc., Nexosome Oncology Holdings, Inc..
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.